Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis

References

• Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–99.
   PubMed Web of Science ®Google Scholar
• Salazar G, Mayes MD. Genetics, epigenetics, and genomics of systemic sclerosis. Rheum Dis Clin North Am. 2015;41(3):345–66.
   PubMed Web of Science ®Google Scholar
• Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62(11):1088–93.
   PubMed Web of Science ®Google Scholar
• Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69(10):1809–15.
   PubMed Web of Science ®Google Scholar
• Hsu VM, Chung L, Hummers LK, Wigley F, Simms R, Bolster M, et al. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Semin Arthritis Rheum. 2014;44(1):55–62.
   PubMed Web of Science ®Google Scholar
• Wangkaew S, Kasitanon N, Phrommintikul A, Sukitawut W, Wichainun R, Louthrenoo W. Pulmonary arterial hypertension in Thai patients with systemic sclerosis. J Med Assoc Thai. 2008;91(2):166–72.
   PubMedGoogle Scholar
• Chung L, Farber HW, Benza R, Miller DP, Parsons L, Hassoun PM, et al. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest 2014;146(6):1494–504.
   PubMed Web of Science ®Google Scholar
• Avouac J, Airò P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol. 2010;37(11):2290–8.
   PubMed Web of Science ®Google Scholar
• Lefèvre G, Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M, et al. Survival and Prognostic Factors in Systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum. 2013;65(9):2412–23.
   PubMed Web of Science ®Google Scholar
• Foocharoen C, Nanagara R, Kiatchoosakun S, Suwannaroj S, Mahakkanukrauh A. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand. Int J Rheum Dis. 2011;14(3):282–9.
   PubMed Web of Science ®Google Scholar
• Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011;63(11):3522–30.
   PubMed Web of Science ®Google Scholar
• Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM 2010;103(2):109–15.
   PubMed Web of Science ®Google Scholar
• Hachulla E, Launay D, Mouthon L, Sitbon O, Berezne A, Guillevin L, French PAH-SSc Network, et al. Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest 2009;136(5):1211–9.
   PubMed Web of Science ®Google Scholar
• Foocharoen C, Mahakkanukrauh A, Suwannaroj S, Nanagara R. Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients. Clin Rheumatol. 2011;30(9):1235–40.
   PubMed Web of Science ®Google Scholar
• Coral-Alvarado P, Pardo AL, Castaño-Rodriguez N, Rojas-Villarraga A, Anaya J-M. Systemic sclerosis: a world wide global analysis. Clin Rheumatol. 2009;28(7):757–65.
   PubMed Web of Science ®Google Scholar
• van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–55.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.
   PubMed Web of Science ®Google Scholar
• King CS, Nathan SD. Pulmonary hypertension due to interstitial lung disease. Curr Opin Pulm Med. 2019;25(5):459–67.
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–75.
   PubMed Web of Science ®Google Scholar
• Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, Itinér AIR-Sclérodermie Study Group, et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum. 2009;60(6):1831–9.
   PubMed Web of Science ®Google Scholar
• Yang X, Mardekian J, Sanders KN, Mychaskiw MA, Thomas J. Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature. Clin Rheumatol. 2013;32(10):1519–31.
   PubMed Web of Science ®Google Scholar
• Muangchan C, Baron M, Pope J, Canadian Scleroderma Research Group. The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review. J Rheumatol. 2013;40(9):1545–56.
   PubMed Web of Science ®Google Scholar
• Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc), et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients. Medicine (Baltimore). 2002;81(2):139–53.
   PubMed Web of Science ®Google Scholar
• Coghlan JG, Denton CP, Grünig E, Bonderman D, Distler O, Khanna D, on behalf of the DETECT study group, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340–9.
   PubMed Web of Science ®Google Scholar
• Schachna L, Wigley FM, Chang B, White B, Wise RA, Gelber AC. Age and risk of pulmonary arterial hypertension in scleroderma. Chest 2003;124(6):2098–104.
   PubMed Web of Science ®Google Scholar
• Cox SR, Walker JG, Coleman M, Rischmueller M, Proudman S, Smith MD, et al. Isolated pulmonary hypertension in scleroderma. Intern Med J. 2005;35(1):28–33.
   PubMed Web of Science ®Google Scholar
• Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005;35(1):35–42.
   PubMed Web of Science ®Google Scholar
• Foocharoen C, Watcharenwong P, Netwijitpan S, Mahakkanukrauh A, Suwannaroj S, Nanagara R. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. Int J Rheum Dis. 2017;20(10):1572–81.
   PubMed Web of Science ®Google Scholar
• Foocharoen C, Suwannachat P, Netwijitpan S, Mahakkanukrauh A, Suwannaroj S, Nanagara R, Scleroderma Research Group. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. Int J Rheum Dis. 2016;19(3):312–20.
   PubMed Web of Science ®Google Scholar
• Jacobsen S, Halberg P, Ullman S, Van Venrooij WJ, Høier-Madsen M, Wiik A, et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol. 1998;37(1):39–45.
   PubMedGoogle Scholar
• Graf SW, Hakendorf P, Lester S, Patterson K, Walker JG, Smith MD, et al. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome. Int J Rheum Dis. 2012;15(1):102–9.
   PubMed Web of Science ®Google Scholar
• Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 1998;114(3):801–7.
   PubMed Web of Science ®Google Scholar
• Park S-K, Kim T-H, Jun J-B, Jung S-S, Bae S, Kim T-Y, et al. The clinical features and autoantibody profile in progressive systemic sclerosis of Korea. J Korean Rheumatol Assoc 2001;8(4):243–52.
   Google Scholar
• Wang J, Assassi S, Guo G, Tu W, Wu W, Yang L, et al. Clinical and serological features of systemic sclerosis in a Chinese cohort. Clin Rheumatol. 2013;32(5):617–21.
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Endo H, Kondo H, Hirohata S. Clinical features of 405 Japanese patients with systemic sclerosis. Mod Rheumatol. 2012;22(2):272–9.
   PubMed Web of Science ®Google Scholar
• Sujau I, Ng CT, Sthaneshwar P, Sockalingam S, Cheah TE, Yahya F, et al. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort. Int J Rheum Dis. 2015;18(4):459–65.
   PubMed Web of Science ®Google Scholar
• Foocharoen C, Peansukwech U, Mahakkanukrauh A, Suwannaroj S, Pongkulkiat P, Khamphiw P, et al. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: a cohort study. Int J Rheum Dis. 2020;23(7):945–57.
   PubMed Web of Science ®Google Scholar
• Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2007;66(6):754–63.
   PubMed Web of Science ®Google Scholar
• Bussone G, Mouthon L. Interstitial lung disease in systemic sclerosis. Autoimmun Rev. 2011;10(5):248–55.
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, ESC Scientific Document Group, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)). Eur Heart J. 2016;37(1):67–119.
   PubMed Web of Science ®Google Scholar
• Habib G, Torbicki A. The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension. Eur Respir Rev. 2010;19(118):288–99.
   PubMedGoogle Scholar
• Augustine DX, Coates-Bradshaw LD, Willis J, Harkness A, Ring L, Grapsa J, et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res Pract. 2018;5(3):G11–24.
   PubMed Web of Science ®Google Scholar
• Weatherald J, Montani D, Jevnikar M, Jaïs X, Savale L, Humbert M. Screening for pulmonary arterial hypertension in systemic sclerosis. Eur Respir Rev. 2019;28(153):190023.
   PubMed Web of Science ®Google Scholar
• Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27(1):136–42.
   PubMed Web of Science ®Google Scholar
• Savarino E, Bazzica M, Zentilin P, Pohl D, Parodi A, Cittadini G, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med. 2009;179(5):408–13.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L, American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–38.
   PubMed Web of Science ®Google Scholar
• Johnson DA, Drane WE, Curran J, Cattau EL, Ciarleglio C, Khan A, et al. Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration? Arch Intern Med. 1989;149(3):589–93.
   PubMedGoogle Scholar